Ang II and Norepinephrine in Cardiac Sympathetic Nerves
心脏交感神经中的 Ang II 和去甲肾上腺素
基本信息
- 批准号:7012200
- 负责人:
- 金额:$ 49.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:angiotensin IIarrhythmiabiological signal transductioncalcium fluxcalmodulincell lineclinical researchexocytosisgenetically modified animalsguinea pigsheart cellhormone regulation /control mechanismhuman tissuelaboratory mousemast cellmyocardial ischemia /hypoxianeurotransmitter receptorneurotransmitter transportnorepinephrinephospholipase Cprotein kinase Creceptor expressionrenin angiotensin systemsodium hydrogen exchangersympathetic nervous systemtissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): In myocardial ischemia, pathologic release of norepinephrine (NE) from sympathetic nerves leads to arrhythmias and death. The mechanisms responsible remain obscure. The overall objective of this grant is to address the important biological issue of whether a local renin-angiotensin system (RAS) plays a significant role in exacerbating NE release in myocardial ischemia. Our preliminary results demonstrate that cardiac mast cells are a novel source of renin, the rate-limiting enzyme responsible for initiating ANG n formation. We hypothesize that degranulation of cardiac mast cells, as occurs in ischemia, is pivotal for activation of local RAS and ANG II formation in the proximity of neuronal ATi receptors (ATiR). In Specific Aim I, we will characterize mast-cell renin from congenic controls (CC) of c-Kit knock out (KO) mice, and from cultured human mast cells (HMC-1). We will also investigate in normoxic and ischemic cardiac models from guinea-pigs, and CC and KO mice, whether locally synthesized ANG n from mast-cell-derived renin activates neuronal ATiR to elicit NE release and reperfusion arrhythmias. We have already ascertained in a cultured-cell model of ischemic sympathetic nerves, that exogenous ANG n stimulates neuronal Na+/H^ exchange (NHE) leading to excessive carrier-mediated NE release. Thus, in Specific Aim n we will study, in human neuroblastoma cells transfected with the cloned rat ATjA receptor (SH-SYSY-ATu), the signal transduction of this ANG H-mediated NHE stimulation. Experiments in SH-SYSY-ATiA cells demonstrate that stimulation of NHE and carrier-mediated NE release by AT)R activation occurs via a Ca +-dependent pathway. Accordingly, our investigation will focus on elucidating the role of PLC, Ca2+, PKC, and calmodulin in this Ca2+-dependent pathway. The overall premise of these experiments is that if we understand the patho-physiological basis for the formation of ANG n in the ischemic heart, and how ANG II exacerbates NE release, then we will also have identified potential therapeutic targets to alleviate ischemic arrhythmias and associated cardiac dysfunctions.
描述(由申请人提供):在心肌缺血中,交感神经病理性释放去甲肾上腺素(NE)会导致心律失常和死亡。 负责的机制仍然不清楚。 该资助的总体目标是解决局部肾素-血管紧张素系统(RAS)是否在加剧心肌缺血中的 NE 释放中发挥重要作用的重要生物学问题。 我们的初步结果表明,心脏肥大细胞是肾素的新来源,肾素是负责启动 ANG n 形成的限速酶。 我们假设心脏肥大细胞的脱颗粒(如缺血时发生的那样)对于激活神经元 ATi 受体 (ATiR) 附近的局部 RAS 和 ANG II 形成至关重要。 在特定目标 I 中,我们将表征来自 c-Kit 敲除 (KO) 小鼠的同源对照 (CC) 和培养的人类肥大细胞 (HMC-1) 的肥大细胞肾素。 我们还将在豚鼠、CC 和 KO 小鼠的常氧和缺血心脏模型中研究来自肥大细胞源性肾素的局部合成的 ANG n 是否会激活神经元 ATiR 以引起 NE 释放和再灌注心律失常。 我们已经在缺血性交感神经的培养细胞模型中确定,外源性 ANG n 刺激神经元 Na+/H^ 交换(NHE),导致载体介导的 NE 过度释放。 因此,在特定目标中,我们将研究在用克隆的大鼠 ATjA 受体 (SH-SYSY-ATu) 转染的人神经母细胞瘤细胞中,这种 ANG H 介导的 NHE 刺激的信号转导。 SH-SYSY-ATiA 细胞中的实验表明,AT)R 激活对 NHE 和载体介导的 NE 释放的刺激是通过 Ca + 依赖性途径发生的。 因此,我们的研究将集中于阐明 PLC、Ca2+、PKC 和钙调蛋白在这一 Ca2+ 依赖性途径中的作用。 这些实验的总体前提是,如果我们了解缺血心脏中 ANG n 形成的病理生理学基础,以及 ANG II 如何加剧 NE 释放,那么我们还将确定减轻缺血性心律失常和相关心功能障碍的潜在治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERTO LEVI其他文献
ROBERTO LEVI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERTO LEVI', 18)}}的其他基金
Histamine Receptor Norepinephrine in Cardiac Dysfunction
组胺受体去甲肾上腺素在心脏功能障碍中的作用
- 批准号:
8260207 - 财政年份:2010
- 资助金额:
$ 49.22万 - 项目类别:
Histamine Receptor Norepinephrine in Cardiac Dysfunction
组胺受体去甲肾上腺素在心脏功能障碍中的作用
- 批准号:
7888932 - 财政年份:2010
- 资助金额:
$ 49.22万 - 项目类别:
Histamine Receptor Norepinephrine in Cardiac Dysfunction
组胺受体去甲肾上腺素在心脏功能障碍中的作用
- 批准号:
8458958 - 财政年份:2010
- 资助金额:
$ 49.22万 - 项目类别:
Histamine Receptor Norepinephrine in Cardiac Dysfunction
组胺受体去甲肾上腺素在心脏功能障碍中的作用
- 批准号:
8068249 - 财政年份:2010
- 资助金额:
$ 49.22万 - 项目类别:
Ang II and Norepinephrine in Cardiac Sympathetic Nerves
心脏交感神经中的 Ang II 和去甲肾上腺素
- 批准号:
7078069 - 财政年份:2005
- 资助金额:
$ 49.22万 - 项目类别:
Ang II and Norepinephrine in Cardiac Sympathetic Nerves
心脏交感神经中的 Ang II 和去甲肾上腺素
- 批准号:
7567590 - 财政年份:2005
- 资助金额:
$ 49.22万 - 项目类别:
Ang II and Norepinephrine in Cardiac Sympathetic Nerves
心脏交感神经中的 Ang II 和去甲肾上腺素
- 批准号:
6869687 - 财政年份:2005
- 资助金额:
$ 49.22万 - 项目类别:
Ang II and Norepinephrine in Cardiac Sympathetic Nerves
心脏交感神经中的 Ang II 和去甲肾上腺素
- 批准号:
7383071 - 财政年份:2005
- 资助金额:
$ 49.22万 - 项目类别:
Ang II and Norepinephrine in Cardiac Sympathetic Nerves
心脏交感神经中的 Ang II 和去甲肾上腺素
- 批准号:
7177556 - 财政年份:2005
- 资助金额:
$ 49.22万 - 项目类别:
PHARMACOLOGY/BIOCHEMISTRY/PATHOPHYSIOLOGY--LEUKOTRIENES
药理学/生物化学/病理生理学--白三烯
- 批准号:
3433481 - 财政年份:1987
- 资助金额:
$ 49.22万 - 项目类别:
相似海外基金
The Role of Ethnic Racial Discrimination on the Development of Anxious Hypervigilance in Latina Youth
民族种族歧视对拉丁裔青少年焦虑过度警觉的影响
- 批准号:
10752122 - 财政年份:2024
- 资助金额:
$ 49.22万 - 项目类别:
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Preliminary Study to Establish Heavy Ion Ablation Therapy for Lethal Ventricular Arrhythmia
重离子消融治疗致死性室性心律失常的初步研究
- 批准号:
23K14885 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Spatiotemporal visualization of adenylyl cyclase signaling
腺苷酸环化酶信号传导的时空可视化
- 批准号:
10664707 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Potassium channels and uteroplacental vessels function in pregnant long QT type 1 women
怀孕长 QT 1 型女性的钾通道和子宫胎盘血管功能
- 批准号:
10665263 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Differences in Women and Men with Atrial Fibrillation
女性和男性房颤患者的差异
- 批准号:
10822952 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
3D Bioprinting of a Bioelectric Cell Bridge for Re-engineering Cardiac Conduction
用于重新设计心脏传导的生物电细胞桥的 3D 生物打印
- 批准号:
10753836 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Developing Explainable AI for Equitable Risk Stratification of Atrial Fibrillation and Stroke
开发可解释的人工智能以实现心房颤动和中风的公平风险分层
- 批准号:
10752585 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:
Personalized Risk Prediction for Prevention and Early Detection of Postoperative Failure to Rescue
个性化风险预测,预防和早期发现术后抢救失败
- 批准号:
10753822 - 财政年份:2023
- 资助金额:
$ 49.22万 - 项目类别:














{{item.name}}会员




